![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Chang Myron
Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.19, Iss.5, 2009-09, pp. : 791-802
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Randomized Phase II Clinical Trials
Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Missing Data in Confirmatory Clinical Trials
Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
An Adaptive Design for Phase II Non-Oncology Dose Selection Clinical Trials
By Su Zheng
Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. :